Hereditary inclusion body myopathy: single patient response to <i>GNE</i> gene Lipoplex therapy

Abstract

Proof of principle for manufacturing of 'clinical grade' GNE gene Lipoplex, clinical safety and activity are demonstrated with GNE gene Lipoplex. Further assessment will involve intravenous administration and subsequent phase I trial involving additional but less severely afflicted HIBM patients.